Tyra Biosciences, Inc. (TYRA)

Tyra Biosciences, Inc. (TYRA) is a healthcare company (biotechnology) based in the United States. The share price is $19.82, up 0.38% on the day, which values the company at $1.37B. Price as of 17 Nov 2026, 17:30 UTC, from Yahoo Finance.

Key facts

Share price
$19.82+0.38% today
Market value
$1.37B
200-week average
$18.388% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Tyra Biosciences, Inc. in more detail

TYRA trades at -6.7× next year's expected earnings. It sits 8% above its 200-week average of $18.38.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

2 of the superinvestors tracked here hold TYRA, including Peter Kolchinsky (3.4% of the portfolio), Julian and Felix Baker (0.0% of the portfolio).

Superinvestors holding TYRA

2 of the investors tracked here report a position in their latest 13F filing.

Tyra Biosciences, Inc. (TYRA): questions and answers

What is Tyra Biosciences, Inc.'s market cap?

Tyra Biosciences, Inc. is valued at $1.37B at a share price of $19.82.

Is TYRA above its 200-week moving average?

Yes. TYRA is 7.8% above its 200-week average of $18.38. Long-term investors watch that line because strong companies rarely trade below it for long.

Does TYRA pay a dividend?

Tyra Biosciences, Inc. does not currently pay a regular dividend.

Which famous investors own TYRA?

In their latest quarterly filings, Peter Kolchinsky (3.4% of the portfolio), Julian and Felix Baker (0.0% of the portfolio) hold TYRA. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Tyra Biosciences, Inc. (TYRA) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/TYRA

Underlying data: Yahoo Finance; company filings with the SEC.